PROCHÁZKOVÁ, Jiřina, Josef SLAVIK, Jan BOUCHAL, Monika LEVKOVA, Zlata HUSKOVA, Jiri EHRMANN, Petra OVESNÁ, Zdenek KOLAR, Pavel SKALICKY, Nicol STRAKOVA, Ondrej ZAPLETAL, Alois KOZUBÍK, Jiřina HOFMANOVÁ, Jan VONDRÁČEK and Miroslav MACHALA. Specific alterations of sphingolipid metabolism identified in EpCAM-positive cells isolated from human colon tumors. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS. AMSTERDAM: ELSEVIER, 2020, vol. 1865, No 9, p. 1-11. ISSN 1388-1981. Available from: https://dx.doi.org/10.1016/j.bbalip.2020.158742.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Specific alterations of sphingolipid metabolism identified in EpCAM-positive cells isolated from human colon tumors
Authors PROCHÁZKOVÁ, Jiřina, Josef SLAVIK, Jan BOUCHAL, Monika LEVKOVA, Zlata HUSKOVA, Jiri EHRMANN, Petra OVESNÁ, Zdenek KOLAR, Pavel SKALICKY, Nicol STRAKOVA, Ondrej ZAPLETAL, Alois KOZUBÍK, Jiřina HOFMANOVÁ, Jan VONDRÁČEK and Miroslav MACHALA.
Edition BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, AMSTERDAM, ELSEVIER, 2020, 1388-1981.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10608 Biochemistry and molecular biology
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.698
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1016/j.bbalip.2020.158742
UT WoS 000552710900012
Keywords in English Sphingolipid metabolism; Colon adenocarcinoma; Lactosylceramide; B4GALTs; EPCAM-positive cells
Tags International impact, Reviewed
Changed by Changed by: Mgr. Jiřina Procházková, Ph.D., učo 43680. Changed: 29/9/2023 10:10.
Abstract
Metabolic reprogramming leading to alterations in lipid metabolism and lipid-mediated signaling may contribute to colorectal cancer (CRC) development and progression. We hypothesized that a detailed description of changes in sphingolipidome of specific cellular subpopulation residing in colon cancer tissue may help to discriminate between normal and transformed colon epithelial cells. Using HPLC-mass spectrometry, we analyzed the EpCAM-positive cells isolated from tumor and adjacent non-tumor tissues of colon cancer patients, aiming to identify potential lipid biomarkers specific for CRC. We then employed RT-qPCR-based methodology in order to analyze expression of SL metabolism-related genes in the isolated EpCAM-positive tumor cells and/or in unseparated colon tumor tissues. We observed significant changes in sphingolipid (SL) species in the EpCAM-positive tumor cells, with the accumulation of lactosylceramide (LacCer) being the most prominent. B4GALT5 and B4GALT6 genes were identified as two potential gene candidates contributing to LacCer accumulation. We further identified additional genes of SL and fatty acid metabolism (e.g. SPHK1, GBA2, NEU3, GLA, FASN, PLA2G10), which were significantly altered in colon tumor tissue. The present results indicate that the EpCAM-positive cells are a major contributor to LacCer accumulation in CRC tissue, and may help to identify novel CRC-specific lipid/gene biomarkers.
PrintDisplayed: 22/8/2024 13:10